Article
Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jun 2004
Krause Stefan W, Gastpar Robert, Andreesen Reinhard, Gross Catharina, Ullrich Heidrun, Thonigs Gerald, Pfister Karin, Multhoff Gabriele
Abstract excerpt
PURPOSE: The 14 amino acid sequence (aa(450-463)) TKDNNLLGRFELSG (TKD) of heat shock protein 70 (Hsp70) was identified as a tumor-selective recognition structure for natural killer (NK) cells. Incubation of peripheral blood lymphocyte cells with TKD plus low-dose interleukin 2 (IL-2) enhances the cytolytic activity of NK cells against Hsp70 membrane-positive tumors, in vitro and in vivo. These data encouraged us...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
